Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease
Inflammatory bowel disease leads to debilitating gastrointestinal symptoms and reduced quality of life, resulting in a significant burden on healthcare utilization and costs. Despite substantial advancements in diagnosis and treatment, there may still be considerable delays in diagnosing some patien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218872/ https://www.ncbi.nlm.nih.gov/pubmed/37240524 http://dx.doi.org/10.3390/jcm12103418 |
_version_ | 1785048876873416704 |
---|---|
author | Rodríguez-Lago, Iago Blackwell, Jonathan Mateos, Beatriz Marigorta, Urko M. Barreiro-de Acosta, Manuel Pollok, Richard |
author_facet | Rodríguez-Lago, Iago Blackwell, Jonathan Mateos, Beatriz Marigorta, Urko M. Barreiro-de Acosta, Manuel Pollok, Richard |
author_sort | Rodríguez-Lago, Iago |
collection | PubMed |
description | Inflammatory bowel disease leads to debilitating gastrointestinal symptoms and reduced quality of life, resulting in a significant burden on healthcare utilization and costs. Despite substantial advancements in diagnosis and treatment, there may still be considerable delays in diagnosing some patients. To reduce disease progression before the full disease spectrum appears and improve prognostic outcomes, several strategies have concentrated on early intervention and prevention. Recent evidence shows that initial immune response changes and endoscopic lesions may exist for years before diagnosis, implying the existence of a preclinical phase of inflammatory bowel disease comparable to findings in other immune-mediated disorders. In this review, we highlight the most relevant findings regarding preclinical inflammatory bowel disease and the prospective role of novel omics techniques in this field. |
format | Online Article Text |
id | pubmed-10218872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102188722023-05-27 Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease Rodríguez-Lago, Iago Blackwell, Jonathan Mateos, Beatriz Marigorta, Urko M. Barreiro-de Acosta, Manuel Pollok, Richard J Clin Med Review Inflammatory bowel disease leads to debilitating gastrointestinal symptoms and reduced quality of life, resulting in a significant burden on healthcare utilization and costs. Despite substantial advancements in diagnosis and treatment, there may still be considerable delays in diagnosing some patients. To reduce disease progression before the full disease spectrum appears and improve prognostic outcomes, several strategies have concentrated on early intervention and prevention. Recent evidence shows that initial immune response changes and endoscopic lesions may exist for years before diagnosis, implying the existence of a preclinical phase of inflammatory bowel disease comparable to findings in other immune-mediated disorders. In this review, we highlight the most relevant findings regarding preclinical inflammatory bowel disease and the prospective role of novel omics techniques in this field. MDPI 2023-05-11 /pmc/articles/PMC10218872/ /pubmed/37240524 http://dx.doi.org/10.3390/jcm12103418 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rodríguez-Lago, Iago Blackwell, Jonathan Mateos, Beatriz Marigorta, Urko M. Barreiro-de Acosta, Manuel Pollok, Richard Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title_full | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title_fullStr | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title_full_unstemmed | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title_short | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease |
title_sort | recent advances and potential multi-omics approaches in the early phases of inflammatory bowel disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218872/ https://www.ncbi.nlm.nih.gov/pubmed/37240524 http://dx.doi.org/10.3390/jcm12103418 |
work_keys_str_mv | AT rodriguezlagoiago recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease AT blackwelljonathan recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease AT mateosbeatriz recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease AT marigortaurkom recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease AT barreirodeacostamanuel recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease AT pollokrichard recentadvancesandpotentialmultiomicsapproachesintheearlyphasesofinflammatoryboweldisease |